Publicacións (195) Publicacións de ENRIQUE MORALES RUIZ

2024

  1. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor-specific anti HLA antibodies

    HLA, Vol. 103, Núm. 6

  2. Detection of binucleated nephrin-marked podocytes by flow cytometry in the urine of patients with obesity

    Journal of Nephrology

  3. Effect of Intravitreal Anti-Endothelial Growth Factor Agents on Renal Function in Patients With Diabetes Mellitus

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1397-1405

  4. Hacia la estandarización de la formación de PoCUS en nefrología: el momento es ahora

    Nefrologia, Vol. 44, Núm. 1, pp. 5-9

  5. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

  6. Strategies for prevention and treatment of SARS-COV-2 infection in patients with chronic kidney disease: Literature review

    Nefrologia, Vol. 44, Núm. 2, pp. 150-158

  7. Strategies for prevention and treatment of SARS-CoV-2 infection in patients with chronic kidney disease: Literature review

    Nefrologia , Vol. 44, Núm. 2, pp. 150-158

2023

  1. Cardiovascular and renal health: Preeclampsia as a risk marker

    Nefrologia, Vol. 43, Núm. 3, pp. 269-280

  2. Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis

    Nefrologia, Vol. 43, Núm. 1, pp. 6-47

  3. Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)

    Clinical Kidney Journal, Vol. 16, Núm. 9, pp. 1384-1402

  4. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  5. New mechanisms involved in the development of cardiovascular disease in chronic kidney disease

    Nefrologia, Vol. 43, Núm. 1, pp. 63-80

  6. Plasma glycocalyx pattern: a mirror of endothelial damage in chronic kidney disease

    Clinical Kidney Journal, Vol. 16, Núm. 8, pp. 1278-1287

  7. Rational use of eculizumab in secondary atypical hemolytic uremic syndrome

    Frontiers in Immunology, Vol. 14

  8. Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults

    Frontiers in Medicine, Vol. 10

  9. Searching for a prognostic index in lupus nephritis

    European journal of medical research, Vol. 28, Núm. 1, pp. 19

  10. Thrombotic microangiopathy in patients with malignant hypertension

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226

  11. Why should genetic testing be incorporated into routine clinical practice in nephrology? The utility of specialized clinics. An emerging need

    Nefrologia, Vol. 43, Núm. 2, pp. 161-166

  12. mTOR inhibitors in a patient with lupus nephritis; why not?

    Nefrologia

  13. mTOR inhibitors in a patient with lupus nephritis; why not?

    Nefrologia